Differentiation, differentiation/gene therapy and cancer (Q41334613)

29 September 2017

1 reference

title

Differentiation, differentiation/gene therapy and cancer (English)

1 reference

29 September 2017

0 references

Scott RE

1

1 reference

PubMed ID

9014206

29 September 2017

language of work or name

1 reference

1 January 1997

1 reference

Pharmacology & Therapeutics

29 September 2017

1 reference

29 September 2017

73

1 reference

29 September 2017

51-65

1 reference

29 September 2017

1

1 reference

Gene therapy utilizing drug resistance genes: a review

29 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Functional antagonism between c-Jun and MyoD proteins: a direct physical association

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

A randomized trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Safety Issues Related to Retroviral-Mediated Gene Transfer in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Induction of hemoglobin accumulation in human K562 cells by hemin is reversible

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Three distinct effects of SV40 T-antigen gene transfection on cellular differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Therapeutic effects of low-dose cytosine arabinoside, alpha-interferon, 1 alpha-hydroxyvitamin D3 and retinoic acid in acute leukemia and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Nonterminally differentiated cells express decreased growth factor responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

13-cis-retinoic acid in the treatment of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Small doses of ARA-C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Gene therapy: current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Phase I evaluation of all-trans-retinoic acid in adults with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Loss of proliferative potential during terminal differentiation coincides with the decreased abundance of a subset of heterogeneous ribonuclear proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Adjuvant treatment of stage I lung cancer with high-dose vitamin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Suppression of human alpha-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Immunization of cancer patients using autologous cancer cells modified by insertion of the gene for tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

The development of gene therapy for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

13-cis-retinoic acid plus interferon-alpha: a phase II clinical study in squamous cell carcinoma of the lung and the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Differential mitogenic effects of methyl isobutyl xanthine and a tumor growth factor on G1-arrested 3T3 T proadipocytes at the predifferentiation GD state and the growth-factor deficiency GS state

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Retinoids in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Insulin-induced mitogenesis associated with transformation by the SV40 large T antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Induction of c-jun independent of PKC, pertussis toxin-sensitive G protein, and polyamines in quiescent SV40-transformed 3T3 T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Differentiation modulates the balance of positive and negative Jun/AP-1 DNA binding activities to regulate cellular proliferative potential: different effects in nontransformed and transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

The myoD Gene Family: Nodal Point During Specification of the Muscle Cell Lineage

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Regulation of the terminal event in cellular differentiation: biological mechanisms of the loss of proliferative potential

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Suppression of tumorigenicity by the cell-cycle-dependent control of cellular differentiation and proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Response of preleukemic syndromes to continuous infusion of low-dose cytarabine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

p21 is a universal inhibitor of cyclin kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2896%2900120-9

7 January 2021

10.1016/S0163-7258(96)00120-9

Identifiers

DOI

1 reference

29 September 2017

1 reference

PubMed ID

9014206